Manappuram Finance Limited has informed the Exchange about General Updates

Management Changes View source PDF Explain this filing

MANAPPURAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹295.80

prior close

₹287.10

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.1%-0.8% vs market

Non Banking Financial Company (NBFC) peers, median of 205sector-0.0%-0.7% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Smallcap 250 and 0.7 pts less than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.4

10m

+1.3

15m

+1.5

30m

+2.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7+0.1-0.8-0.0-0.7

Next day

-4.5-1.0-3.5-1.0-3.5

-6.5-2.8-3.6-3.8-2.7

-8.7-4.9-3.8-3.9-4.8

-9.6-3.6-6.0-3.8-5.7

-11.0-3.8-7.1-4.3-6.6

-10.7-4.1-6.7-4.5-6.2

15d

-12.4-7.8-4.6-6.8-5.6

-13.9-8.6-5.3-10.8-3.1

-1.8+4.2-6.0+0.5-2.3

+11.8+6.1+5.8-1.1+12.9

UpDownMarket · Nifty Smallcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 205Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Manappuram Finance has informed the stock exchanges that its Chief Executive Officer and Key Managerial Personnel, Mr. Deepak Reddy, is taking medical leave of absence starting February 25, 2026. He will travel overseas for medical treatment, with the leave expected to last between 90 and 120 days depending on how the treatment progresses. The company has made this disclosure under SEBI Listing Regulations and uploaded it on its website. No replacement or interim CEO arrangement has been mentioned in this filing.

Likely market impact

A temporary leadership gap at the top may create short-term uncertainty for investors, though a medical leave is not the same as a resignation. Shareholders should watch for any follow-up announcement about interim management arrangements during his absence.